Clinical Trial Update: A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 prospective study evaluating daily adaptive radiotherapy to reduce doses to organs at risk in head and neck canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED